303 related articles for article (PubMed ID: 27196810)
1. Application of nanostructured drug delivery systems in immunotherapy of cancer: a review.
Asadi N; Davaran S; Panahi Y; Hasanzadeh A; Malakootikhah J; Fallah Moafi H; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):18-23. PubMed ID: 27196810
[TBL] [Abstract][Full Text] [Related]
2. The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy.
Hosseini M; Haji-Fatahaliha M; Jadidi-Niaragh F; Majidi J; Yousefi M
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1051-61. PubMed ID: 25612903
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles for tumor immunotherapy.
Zang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
Eur J Pharm Biopharm; 2017 Jun; 115():243-256. PubMed ID: 28323111
[TBL] [Abstract][Full Text] [Related]
4. The potential of nanoparticle vaccines as a treatment for cancer.
Urbanavicius D; Alvarez T; Such GK; Johnston APR; Mintern JD
Mol Immunol; 2018 Jun; 98():2-7. PubMed ID: 29395251
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
Klippstein R; Pozo D
Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapies to improve tumor immunotherapy.
Begley J; Ribas A
Clin Cancer Res; 2008 Jul; 14(14):4385-91. PubMed ID: 18628452
[TBL] [Abstract][Full Text] [Related]
7. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
Nakamura T
Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
[TBL] [Abstract][Full Text] [Related]
8. Engineering the immune system with particles, step-by-step.
De Geest BG
Mol Immunol; 2018 Jun; 98():25-27. PubMed ID: 29526503
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticulate immunotherapy for cancer.
Kapadia CH; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2015 Dec; 219():167-180. PubMed ID: 26432555
[TBL] [Abstract][Full Text] [Related]
10. The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective.
Li Y; Ayala-Orozco C; Rauta PR; Krishnan S
Nanoscale; 2019 Oct; 11(37):17157-17178. PubMed ID: 31531445
[TBL] [Abstract][Full Text] [Related]
11. Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.
Hamdy S; Haddadi A; Hung RW; Lavasanifar A
Adv Drug Deliv Rev; 2011 Sep; 63(10-11):943-55. PubMed ID: 21679733
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.
Musetti S; Huang L
ACS Nano; 2018 Dec; 12(12):11740-11755. PubMed ID: 30508378
[TBL] [Abstract][Full Text] [Related]
13. Application of nanotechnology in circumventing immunotolerance.
Ma Y; Shen Y; Zhu B; Li D; Liu J
Pharmazie; 2020 Oct; 75(10):470-477. PubMed ID: 33305719
[TBL] [Abstract][Full Text] [Related]
14. Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.
Li W; Wei H; Li H; Gao J; Feng SS; Guo Y
Nanomedicine (Lond); 2014 Nov; 9(16):2587-605. PubMed ID: 25490427
[TBL] [Abstract][Full Text] [Related]
15. Cancer immunotherapy.
Schuster M; Nechansky A; Kircheis R
Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-based immunotherapy for cancer.
Shao K; Singha S; Clemente-Casares X; Tsai S; Yang Y; Santamaria P
ACS Nano; 2015 Jan; 9(1):16-30. PubMed ID: 25469470
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.
Torres Andón F; Alonso MJ
J Drug Target; 2015; 23(7-8):656-71. PubMed ID: 26453162
[TBL] [Abstract][Full Text] [Related]
18. Targeting myeloid cells using nanoparticles to improve cancer immunotherapy.
Amoozgar Z; Goldberg MS
Adv Drug Deliv Rev; 2015 Aug; 91():38-51. PubMed ID: 25280471
[TBL] [Abstract][Full Text] [Related]
19. Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.
Lim S; Park J; Shim MK; Um W; Yoon HY; Ryu JH; Lim DK; Kim K
Theranostics; 2019; 9(25):7906-7923. PubMed ID: 31695807
[TBL] [Abstract][Full Text] [Related]
20. Delivering safer immunotherapies for cancer.
Milling L; Zhang Y; Irvine DJ
Adv Drug Deliv Rev; 2017 May; 114():79-101. PubMed ID: 28545888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
